Nektar Therapeutics (NKTR)
58.78
+1.50
(+2.62%)
USD |
NASDAQ |
Dec 09, 16:00
58.78
0.00 (0.00%)
Pre-Market: 08:24
Nektar Therapeutics Total Liabilities (Quarterly): 216.26M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 91.08B |
| Amicus Therapeutics, Inc. | 638.39M |
| Regeneron Pharmaceuticals, Inc. | 9.212B |
| Rigel Pharmaceuticals, Inc. | 124.92M |
| Zevra Therapeutics, Inc. | 136.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 301.35M |
| Shareholders Equity (Quarterly) | 85.09M |
| Debt to Equity Ratio | 1.964 |
| Current Ratio | 4.241 |
| Net Debt Paydown Yield | 1.07% |